BioLine RX Ltd BLRX:NASDAQ

RT Quote | USD
Last | 05/21/24 EDT
0.6229quote price arrow up+0.0007 (+0.1125%)
Volume
130,725
52 week range
0.55 - 2.53
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.6222
  • 52 Week High2.53
  • 52 Week High Date09/05/23
  • 52 Week Low0.55
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap49.794M
  • Shares Out79.94M
  • 10 Day Average Volume0.22M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change-60.32

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.6222
  • 52 Week High2.53
  • 52 Week High Date09/05/23
  • 52 Week Low0.55
  • 52 Week Low Date04/26/24
  • Market Cap49.794M
  • Shares Out79.94M
  • 10 Day Average Volume0.22M
  • Dividend-
  • Dividend Yield-
  • Beta1.49
  • YTD % Change-60.32

RATIOS/PROFITABILITY

  • EPS (TTM)-0.95
  • P/E (TTM)-0.66
  • Fwd P/E (NTM)-0.60
  • EBITDA (TTM)-41.607M
  • ROE (TTM)-189.23%
  • Revenue (TTM)4.80M
  • Gross Margin (TTM)23.08%
  • Net Margin (TTM)-1,262.79%
  • Debt To Equity (MRQ)87.66%

EVENTS

  • Earnings Date08/03/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioLine RX Ltd

 

Profile

MORE
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Aharon Schwartz Ph.D.
Chairman of the Board
Philip Serlin
Chief Executive Officer
Mali Zeevi
Chief Financial Officer
Ella Sorani
Vice President - Development
Abi Vainstein-Haras
Vice President-Clinical & Medical Affairs
Address
Modi'in Technology Park
2 HaMa'ayan Street
Modiin
7177871
Israel

Top Peers

SYMBOLLASTCHG%CHG
DYAI
Dyadic International Inc
1.67+0.06+3.44%
KZR
Kezar Life Sciences Inc
0.7759+0.006+0.7793%
LPCN
Lipocine Inc
6.57+0.20+3.14%
HCWB
HCW Biologics Inc
1.11UNCHUNCH
IKNA
Ikena Oncology Inc
1.38-0.02-1.43%